What's new in Kawasaki disease?

Article

Revised guidelines help evaluate the child who doesn't meet all the classic criteria for KD and provide a framework for long-term management based on the risk of myocardial infarction.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
David Brousseau, MD, highlights impact of timely opioid dosing in pediatric sickle cell pain
August's FDA Focus: Approvals and pipeline updates in pediatrics | Image credit: Contemporary Pediatrics
© 2025 MJH Life Sciences

All rights reserved.